HighPoint Advisor Group LLC
- SEC CIK
- 0001616034
- Latest filing
- Aug 5, 2026
NRXP holding history
NRX Pharmaceuticals, Inc. in every 13F filed by HighPoint Advisor Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRXP overviewAll 13F holders of NRXPFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −43,501−100.0% | Sold out | Holders |
| Q4 2023 | 43,501 | $23.0K | <0.1% | – | No prior filing | Holders |
| Q3 2022 | – | – | – | – | Not filed | Holders |
| Q2 2022 | 43,501 | $24.0K | <0.1% | – | No prior filing | Holders |
| Q4 2021 | – | – | – | – | Not filed | Holders |
| Q3 2021 | 43,501 | $403.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 43,501 | $505.0K | 0.1% | +43,501 | New | Holders |